Evidence map›Paper›PMID 39015370›Full record

ArticleFrontiers in pharmacology2024

Pharmacokinetics, safety, and efficacy of Fuqi Guben Gao in the treatment of kidney-yang deficiency syndrome: a randomized, double-blind phase I trial.

Wei-Yi Cao, Jun-Yu Liu, Min Sun, Jing-Kun Wang, Fang Lu, Qiao-Ning Yang, Wan-Tong Zhang, Ming-Jie Zi, Bai-E Zhang, Hong-Bin Liu and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Wei-Yi Cao *Institute of Clinical Pharmacology of Xiyuan Hospital, National Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences, Beijing, China.
Jun-Yu Liu *Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Yunnan Institute of Materia Medica, Kunming, Yunnan, China.
Min Sun *Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Yunnan Institute of Materia Medica, Kunming, Yunnan, China.
Jing-Kun WangYunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Yunnan Institute of Materia Medica, Kunming, Yunnan, China.
Fang LuInstitute of Clinical Pharmacology of Xiyuan Hospital, National Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences, Beijing, China.
Qiao-Ning YangInstitute of Clinical Pharmacology of Xiyuan Hospital, National Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences, Beijing, China.
Wan-Tong ZhangInstitute of Clinical Pharmacology of Xiyuan Hospital, National Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences, Beijing, China.
Ming-Jie ZiInstitute of Clinical Pharmacology of Xiyuan Hospital, National Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences, Beijing, China.
Bai-E ZhangYunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Yunnan Institute of Materia Medica, Kunming, Yunnan, China.
Hong-Bin LiuYunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Yunnan Institute of Materia Medica, Kunming, Yunnan, China.
Shu-Ge WangInstitute of Clinical Pharmacology of Xiyuan Hospital, National Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences, Beijing, China.
Yi WuInstitute of Clinical Pharmacology of Xiyuan Hospital, National Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences, Beijing, China.
Rong-Zu WuKunming Municipal Hospital of Traditional Chinese Medicine, Kunming, Yunnan, China.
Wen-Di WuKunming Municipal Hospital of Traditional Chinese Medicine, Kunming, Yunnan, China.
Rui LiInstitute of Clinical Pharmacology of Xiyuan Hospital, National Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences, Beijing, China.
Zhao-Yun ZhuYunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Yunnan Institute of Materia Medica, Kunming, Yunnan, China.
Rui GaoInstitute of Clinical Pharmacology of Xiyuan Hospital, National Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

efficacyFuqi Guben Gaokidney-yang deficiency syndromemetabonomicspharmacokinetics

Identifiers

PMID39015370
PMCPMC11250459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.